As demonstrated in this study, in which CD33+ AML cell lines lacking detectable expression of CD80 or CD86 were efficiently killed by AMG 330, in vitro cytotoxicity induced by BiTE antibody constructs is indeed independent of CD80 or CD86-induced T-cell activation. The gene discussed is CD80; the disease is acute myeloid leukemia.